Monday, September 27, 2021
Home Tags Pharma

Pharma Related News

neurodegenerative-diseases

A new hope for treating neurodegenerative diseases

NervGen’s NVG-291 is a new drug with the potential to treat a range of neurodegenerative diseases, including Alzheimer's and MS. IT is the Holy Grail...
COVID-19 vaccine

Trial begins for world-first multivariant COVID-19 vaccine booster

A phase one trial for the world’s first multivariant COVID-19 booster vaccine has been launched in Manchester. Initiated by pharmaceutical company Gritstone, in partnership with...
HPV vaccine

Defence Therapeutics unveil novel HPV vaccine development programme

Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
cancer-vaccine

Cancer vaccine developed using Oxford-AstraZeneca vaccine technology

Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer. Researchers at the...
opioid-overdose

Researchers issue opioid warning as they reveal overdose findings

Hundreds of patients could have died from an accidental overdose of prescription opioids, the findings from a recent study have revealed. Research led by Dr...
heart-failure-patients-AI

AI identifies heart failure patients best suited to beta-blocker treatment

A new AI-based approach could help to quickly and easily identify the best treatment options for heart failure patients. Researchers from the University of Birmingham...
drug-delivery-Defence-Therapeutics

Defence Therapeutics selects new variants to optimise drug delivery

Following a thorough evaluation process, Defence Therapeutics has selected the eight most successful variants of its Accum™ drug delivery technology. Biotechnology company Defence Therapeutics continually works...
heart-failure

Lung disease drug offers hope for heart failure patients

A drug currently used to treat lung fibrosis could be repurposed to treat heart failure patients, an early phase trial has suggested. Doctors and scientists...
intranasal-vaccine

Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk

Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine. Scientists from Lancaster University have carried out pre-clinical trials of a...
SARS-CoV-2-infection

Cholesterol drug could reduce SARS-CoV-2 infection by up to 70%

Scientists have identified a licensed drug that they say could significantly reduce the risk of COVID-19 infection. An international study, led by the University of...
Defence-Therapeutics

Defence Therapeutics partners with pharmaceutical experts

Biotechnology company Defence Therapeutics has partnered with a pharmaceutical consultancy to maximise the potential of its developments. In a bid to strengthen its development of...

NervGen: Vying to disrupt the treatment of degenerative diseases

Backed by over three decades of thorough research, NervGen’s latest drug candidate has the potential to reverse damage caused by degenerative conditions. Canadian R&D innovator...
COVID-19-blood-clots

Existing drugs could prevent blood clots in severe COVID-19 cases

New findings that COVID-19-related blood clots may be caused by an abnormal antibody response could help to identify preventative treatments. Researchers have demonstrated how antibodies...
Pfizer-vaccine

Longer interval between Pfizer vaccine doses boosts antibody protection

A longer dosing schedule for the Pfizer COVID-19 vaccine triggered the most effective immune response, new research has found. A new and extensive pre-print study...
vaccine-efficacy

Modifying the immune system could enhance vaccine efficacy

Vaccine efficacy could be enhanced using new insights about the immune system, researchers say. Immunologists at St. Jude Children's Research Hospital have discovered a biological...
COVID-19-AI

AI technology identifies 160 possible new drug treatments for COVID-19

Scientists have discovered a total of 200 approved drugs that could treat COVID-19, but only 40 are currently being tested in clinical trials. Researchers from...
CoronaVac

CoronaVac COVID-19 vaccine safe for children as young as three

A clinical trial has proven that the CoronaVac COVID-19 vaccine is safe for children and adolescents aged between three to 17. The CoronaVac vaccine, which...

Defence Therapeutics: Transforming drug delivery and improving treatment

Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
COVID-treatment

App aids safe prescribing of COVID-19 treatment drugs

A new mobile app has been launched to advise on the safe prescribing of experimental drugs for the treatment of COVID-19. The University of Liverpool...

Towards a cancer revolution with new targeted therapeutics

Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery. Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest